Here are three points:
1. EndoChoice has declined 60.1 percent since September 18, 2015 and is trending downward.
2. The company’s stock has underperformed the S&P500 by 66.73 percent.
3. The company has a market cap of $147.51 million.
More articles on GI/endoscopy:
Dr. Asad Rafiq joins Blessing Physician Services: 3 notes
Medtronic issues voluntary recall Capnostream monitor battery pack: 4 points
Dr. Steven Ayres designated AGA fellow — 5 highlights
